Failure of a cetuximab/bevacizumab schedule in a patient with metastatic desmoplastic small round-cell tumour refractory to chemotherapy

Clin Oncol (R Coll Radiol). 2005 Aug;17(5):393-4. doi: 10.1016/j.clon.2005.03.010.
No abstract available

Publication types

  • Letter

MeSH terms

  • Abdominal Neoplasms / diagnostic imaging
  • Abdominal Neoplasms / drug therapy*
  • Abdominal Neoplasms / pathology
  • Abdominal Neoplasms / surgery
  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bevacizumab
  • Carcinoma, Small Cell / diagnostic imaging
  • Carcinoma, Small Cell / drug therapy*
  • Carcinoma, Small Cell / pathology
  • Carcinoma, Small Cell / surgery
  • Cetuximab
  • Drug Resistance, Neoplasm*
  • Exanthema / chemically induced
  • Humans
  • Male
  • Neoplasm Metastasis
  • Tomography, X-Ray Computed

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Cetuximab